Muromonab-CD3 therapy for refractory rejections after liver transplantation: A single-center experience during two decades in Japan

Daisuke Ueda, Tomohide Hori, Justin H. Nguyen, Shinji Uemoto

Research output: Contribution to journalArticle

4 Scopus citations

Fingerprint Dive into the research topics of 'Muromonab-CD3 therapy for refractory rejections after liver transplantation: A single-center experience during two decades in Japan'. Together they form a unique fingerprint.

Medicine & Life Sciences